Chandrayaan-3's health normal: ISRO updates after successful orbit-raising manoeuvre
New Delhi: Scientists successfully executed the initial orbit-raising manoeuvre of the Chandrayaan-3 spacecraft on Saturday, Indian Space Research Organisation (ISRO) said.
ISRO stated through a social media post that the health of the spacecraft is deemed "normal".
As per the space agency, Chandrayaan-3 is currently positioned in an orbit that ranges from a closest distance of 173 km to the Earth, to a farthest distance of 41,762 km from the Earth.
"Chandrayaan-3 Mission update: The spacecraft's health is normal. The first orbit raising manoeuvre (Earthbound firing-1) was successfully performed at ISTRAC/ISRO, Bengaluru. Spacecraft is now in 41762kms x 173kms orbit," ISRO said.
Chandrayaan-3 Mission update:
— ISRO (@isro) July 15, 2023
The spacecraft's health is normal.
The first orbit-raising maneuver (Earthbound firing-1) is successfully performed at ISTRAC/ISRO, Bengaluru.
Spacecraft is now in 41762 km x 173 km orbit. pic.twitter.com/4gCcRfmYb4
On July 14, ISRO successfully launched Chandrayaan-3, the third edition of its Moon exploration programme from the Satish Dhawan Space Centre, Sriharikota.
ISRO is aiming at making a soft landing on the south pole of the Moon, which is still unexplored, that would make India achieve a rare feat.
To date, only three nations, namely the United States, China, and Russia have successfully achieved the feat of landing on the lunar surface.
IBNS
Senior Staff Reporter at Northeast Herald, covering news from Tripura and Northeast India.
Related Articles

Shocking: Nearly 5 million children still die before age 5 every year — Here’s why
An estimated 4.9 million children died before their fifth birthday in 2024, including 2.3 million newborns, according to new United Nations estimates released on Tuesday – highlighting a worrying slowdown in global progress on child survival.

AstraZeneca India secures CDSCO approval for Durvalumab in advanced liver cancer
AstraZeneca Pharma India Ltd. (AZPIL) has announced that the Central Drugs Standard Control Organisation (CDSCO) has granted approval for an additional indication of Durvalumab.

Too hot to move? Study warns climate change may trigger mass inactivity and deaths
Rising global temperatures due to climate change could push millions of people into physical inactivity by 2050, potentially leading to hundreds of thousands of premature deaths and billions of dollars in lost productivity, according to a modelling study published in The Lancet Global Health.

Smoking fathers, sick kids? Study finds alarming diabetes link
A father’s nicotine exposure can affect his offspring’s ability to process sugar and may contribute to diabetes risk, according to new research using lab mice at the University of California, Santa Cruz.
Latest News

'No role in Hindi version': Nora Fatehi reacts to backlash over controversial song

IG Assam Rifles reviews security situation in Dima Hasao; troops praised for exemplary performance

Another jolt to Congress! Lok Sabha MP Bordoloi joins BJP before Assam polls

Ranveer Singh makes a big claim over Dhurandhar 2 ahead of its March 19 release

